MSH6 and Lynch syndrome: A meta-analysis of 5 different MSH6 mutation positive Lynch syndrome cohorts displayed a much lower lifetime risk of CRC at ~20% [33], which is an indication that our sample cohort might be too small to produce reliable lifetime risk figures.